logo
logo
AI Products 

Fetal Fibroblast Cell Culture Is Fastest Growing Segment Fueling Growth In The Preterm Birth And Prom Testing Market

avatar
Pooja salve
Fetal Fibroblast Cell Culture Is Fastest Growing Segment Fueling Growth In The Preterm Birth And Prom Testing Market

The global Preterm Birth And Prom Testing Market is estimated to be valued at US$ 1.69 Bn in 2023 and is expected to exhibit a CAGR of 12% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

The preterm birth and prom testing market deals with tests and assays that help in determining the risk of premature birth through the analysis of various biochemical markers found in maternal blood, urine or vaginal secretions. These tests assess fetal fibronectin levels, cervical length, fetal fibrillin levels and more to assess the risk of preterm birth. Advances in cell culture techniques have expanded options for assessing genetic and molecular factors through fetal cell cultures grown from amniotic fluid samples.

Market Key Trends:

One of the key trends in the preterm birth and prom testing market is the increasing use of fetal fibroblast cell culture. Fetal cells grown in cell culture provide biomaterial that can be used for various molecular and genetic analyses to gain insights about fetal health and development. Since these cells carry the genome of the fetus, they offer a lens into causes of preterm labor at the genetic and molecular level. Advances in cell culture protocols have made it possible to culture fetal fibroblast cells from amniotic fluid samples in a reliable manner. This is fueling the adoption of cell culture-based tests for advanced preterm birth risk assessment.

Segment Analysis

The global preterm birth and prom testing market is segmented into product, method, application, and end user. Based on product, the market is segmented into consumables and equipment. The consumables segment is dominating the preterm birth and prom testing market as it requires recurrent procurement of consumables such as assay kits, reagents, and others. Based on method, the market is segmented into biomarker testing, fetal fibronectin test (fFN), ultrasound, and others. The biomarker testing segment is dominating the market as it allows recognizing those at higher risk of preterm delivery by analyzing a number of different proteins and metabolites in various body fluids.

Key Takeaways

Global Preterm Birth And Prom Testing Market Demand is expected to witness high growth, exhibiting a CAGR of 12% over the forecast period, due to increasing incidences of preterm births globally.

Regional analysis: North America is expected to dominate the global preterm birth and prom testing market over the forecast period. The dominance is attributed to the increasing number of preterm births and growing awareness regarding preterm birth testing in the region.

Key players operating in the preterm birth and prom testing market are Abbott Laboratories, Biosynex, Qiagen Sciences LLC, Clinical Innovations LLC, Sera Prognostics, The Cooper Companies Inc., Medixbiochemica, Hologic Inc., IQ Products, NX Prenatal Inc., Promega Corporation, Medical Predictive Technologies Inc., Biosynex, Clinical Innovations LLC, NX Prenatal Inc., Medixbiochemica, Qiagen Sciences LLC, Sera Prognostics Inc., Insight Pharmaceuticals LLC, Creative Diagnostics. Abbott Laboratories is dominating the market with its extensive product portfolio for preterm birth and prom testing.


Read More- https://www.marketwebjournal.com/preterm-birth-and-prom-testing-market-size-share-and-demand/

collect
0
avatar
Pooja salve
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more